Trialing Period
A temporary test phase using external neurostimulation before permanent implantation to assess therapeutic efficacy.
Full Definition
The trialing period is a crucial phase in neuromodulation therapy where patients undergo temporary stimulation using externalized leads connected to an external pulse generator. This trial, typically lasting 5-14 days, allows assessment of pain relief, functional improvement, and patient tolerance before proceeding to permanent implant placement. During the trial, leads are positioned at target locations but remain externalized through the skin, connected to a battery-powered external device worn by the patient. Success criteria typically include 50% or greater pain reduction and improved quality of life measures. The trialing period helps identify suitable candidates for permanent implantation and can prevent unnecessary procedures in non-responders.
Usage
Usage note: Use 'trialing' rather than 'trial' when referring to the testing process.
In Context
- "The patient achieved 75% pain reduction during the seven-day trialing period." — Clinical assessment
- "Trialing period protocols require daily wound care and infection monitoring." — Post-procedural guidelines